TheEdgeResearch
Home / Stocks / NMAD

NOMAD Power Solutions, Inc. (NMAD)

NASDAQ Healthcare Biotechnology
$4.07 ▲ +0.42%
Market Cap
$50.3M
Sector
Healthcare
Industry
Biotechnology
Beta
1.30
52-Wk Range
2.36-8.38
CEO
Geordan G. Pursglove
Country
US
Currency
USD

NOMAD Power Solutions, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Boca Raton, FL, US. The stock last traded at $4.07, up 0.42% on the session, giving a market capitalisation of $50.3M. Its beta of 1.30 implies it has historically moved more than the broad market.

Company profile
Exchange
NASDAQ
Employees
3
IPO date
2020-11-24
Headquarters
Boca Raton, FL, US
About NOMAD Power Solutions, Inc.

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.

More research on NMAD
NMAD technical analysis NMAD TheEdge Score Compare against peers
Open full interactive analysis & DCF →